Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪5.68 M‬USD
−1.1510USD
‪−5.00 M‬USD
‪3.55 M‬
Beta (1Y)
2.04

About Protagenic Therapeutics, Inc.

Headquarters
New York
Employees (FY)
3
Founded
1994
FIGI
BBG010B6TKX0
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.